Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With ETV6-NTRK3 Fusion-Positive Carcinoma Harboring the NTRK3 G623R Solvent-Front Mutation.

Hanf, Dorothea; Heining, Christoph; Laaber, Karin; Nebelung, Heiner; Uhrig, Sebastian; Hutter, Barbara; Jahn, Arne; Richter, Daniela; Aust, Daniela; Herbst, Friederike; Fröhling, Stefan; Glimm, Hanno; Folprecht, Gunnar

Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With ETV6-NTRK3 Fusion-Positive Carcinoma Harboring the NTRK3 ^G623R Solvent-Front Mutation.

Hanf, Dorothea; Heining, Christoph; Laaber, Karin; Nebelung, Heiner; Uhrig, Sebastian; Hutter, Barbara; Jahn, Arne; Richter, Daniela; Aust, Daniela; Herbst, Friederike; Fröhling, Stefan; Glimm, Hanno; Folprecht, Gunnar.

Affiliation

Hanf D; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) and DKFZ Dresden, Dresden, Germany.
Heining C; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus Dresden at TU Dresden, Dresden, Germany.
Laaber K; German Cancer Consortium (DKTK), Dresden, Germany.
Nebelung H; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) and DKFZ Dresden, Dresden, Germany.
Uhrig S; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus Dresden at TU Dresden, Dresden, Germany.
Hutter B; German Cancer Consortium (DKTK), Dresden, Germany.
Jahn A; Translational Functional Cancer Genomics, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Richter D; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Aust D; Department of Radiology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.
Herbst F; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Fröhling S; Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases, DKFZ, Heidelberg, Germany.
Glimm H; German Cancer Consortium (DKTK), Heidelberg, Germany.
Folprecht G; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

JCO Precis Oncol ; 52021.

Article de En | MEDLINE | ID: mdl-34250401

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pyridines / Tumeurs de la thyroïde / Anilides Limites: Adult / Humans / Male Langue: En Journal: JCO Precis Oncol Année: 2021 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google